Immunex Corp. (IMNX)
Bruce Schackman of Furman Selz removed IMNX from the firm's Recommended List. The announcement that majority shareholder American Cyanamid may make open market purchases of IMNX provides an opportunity for investors to exit the stock at a reasonable price, said